A61P 27/04
Artificial tears
Official title: Artificial tears; Irrigation solutions
A61P27/04 (Artificial tears) appears on 979 US grants and 1,697 published applications in this corpus.
Search patents in A61P- Granted patents
- 979
- Published applications
- 1,697
- Assignees
- 563
- Inventors
- 2,311
- Latest grant
- 15 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1994 | 1 | 0 |
| 1995 | 0 | 0 |
| 1996 | 2 | 0 |
| 1997 | 4 | 0 |
| 1998 | 2 | 0 |
| 1999 | 1 | 0 |
| 2000 | 4 | 0 |
| 2001 | 12 | 3 |
| 2002 | 30 | 19 |
| 2003 | 10 | 23 |
| 2004 | 4 | 31 |
| 2005 | 8 | 35 |
| 2006 | 10 | 44 |
| 2007 | 8 | 44 |
| 2008 | 20 | 66 |
| 2009 | 15 | 64 |
| 2010 | 33 | 80 |
| 2011 | 27 | 87 |
| 2012 | 52 | 86 |
| 2013 | 90 | 111 |
| 2014 | 77 | 107 |
| 2015 | 64 | 95 |
| 2016 | 54 | 71 |
| 2017 | 56 | 89 |
| 2018 | 50 | 99 |
| 2019 | 61 | 81 |
| 2020 | 64 | 88 |
| 2021 | 57 | 97 |
| 2022 | 39 | 76 |
| 2023 | 38 | 60 |
| 2024 | 42 | 54 |
| 2025 | 27 | 48 |
| 2026 | 17 | 39 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Eye care composition containing l-ergothioneine, and preparation method therefor and use thereof15 Sep 2026US 12,734,154 B2Gene III Biotechnology Co., Ltd.
- TSG6 polypeptide fragment for dry eye disease4 Aug 2026US 12,697,368 B2The University of Manchester
- Medicament for preventing and/or treating dry eye14 Jul 2026US 12,678,443 B2Boehringer Ingelheim International GmbH
- Ophthalmic pharmaceutical composition, preparation methods and uses of the same23 Jun 2026US 12,661,317 B2Sophia Holdings, S.A. De C.V.
- Compositions and methods of treating dry eye syndrome and other traumatized non-keratinized epithelial surfaces23 Jun 2026US 12,661,374 B2Eye Care International, LLC
- Sulfurized imidazoles in ophthalmic formulations8 Oct 2026US 2026/0306457 A1Geneiii Biotech Company Ltd.
- Medicament for preventing and/or treating dry eye17 Sep 2026US 2026/0272940 A1Boehringer Ingelheim International GmbH
- Dry eye treatment17 Sep 2026US 2026/0273029 A1Inoculus Ventures, LLC
- Use of calcium sensing receptor antagonists for treating ocular disorders10 Sep 2026US 2026/0263410 A1
- Eye drops20 Aug 2026US 2026/0240899 A1Nof Corporation
Most cited
By later US patents
- Modulators of ATP-binding cassette transporters157US 7,495,103 B2Vertex Pharmaceuticals Incorporated · 2009
- Indole derivatives as CFTR modulators130US 7,645,789 B2Vertex Pharmaceuticals Incorporated · 2010
- Conveniently implantable sustained release drug compositions126US 7,906,136 B2Ramscor, Inc. · 2011
- Modulators of ATP-binding cassette transporters124US 7,659,268 B2Vertex Pharmaceuticals Incorporated · 2010
- Modulators of ATP-binding cassette transporters121US 7,776,905 B2Vertex Pharmaceuticals Incorporated · 2010